CELG

Celgene Corporation News Headlines

$120.31
*  
1.22
1%
Get CELG Alerts
*Delayed - data as of Mar. 2, 2015  -  Find a broker to begin trading CELG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Investors Are Best To Avoid The IShares Nasdaq Biotechnology ETF
3/2/2015 10:24:00 AM - Seeking Alpha


Celgene : EC Approves ABRAXANE For First-Line Treatment Of Patients With NSCLC
3/2/2015 9:50:00 AM - RTT News


Amgen's Long Case Strengthens After Kyprolis Data
3/2/2015 8:41:00 AM - Seeking Alpha


ModernGraham Quarterly Valuation Of Celgene Corporation
2/26/2015 10:48:00 AM - Seeking Alpha


Heavy Institutional Buying Is Occurring In MEI Pharma, Topline Data Due In Mid-March
2/26/2015 8:30:00 AM - Seeking Alpha


SanDisk Has Disappointed Twice - Cramer's Lightning Round (2/25/15)
2/26/2015 5:51:00 AM - Seeking Alpha


ABRAXANE Now Reimbursed In Italy As First-Line Treatment For Pancreatic Cancer
2/24/2015 8:15:00 AM - RTT News


Market Is Not In A Bubble - Cramer's Mad Money (2/23/15)
2/24/2015 7:40:00 AM - Seeking Alpha


Celgene To Present At RBC Capital Markets Conference; Webcast At 8:00 AM ET
2/24/2015 7:00:00 AM - RTT News


Enbridge Energy Partners Is Cheap - Cramer's Lightning Round (2/23/15)
2/24/2015 5:53:00 AM - Seeking Alpha


Celgene (CELG) Stock Gained Today on European Commission Approval of Revlimid
2/20/2015 5:01:00 PM - TheStreet


Seeking Alpha's Biotech Weekly: Sanofi's New Chief, Sarissa Shakes Ariad, And More
2/20/2015 4:00:00 PM - Seeking Alpha


Comparing America's Next 3 Biotechnology Companies
2/20/2015 12:35:00 PM - Seeking Alpha


EC Approves REVLIMID For Adult Patients With Untreated Multiple Myeloma
2/20/2015 3:59:00 AM - RTT News


Makers of pricey drugs working on new payment model
2/19/2015 10:10:00 AM - Seeking Alpha


Celgene: Still An Attractive Core Growth Play
2/18/2015 5:02:00 PM - Seeking Alpha


Celgene: FDA Allows Wider Use of Revlimid in Multiple Myeloma
2/18/2015 10:27:00 AM - Dow Jones Business News


Celgene Says FDA Expanded Existing Indication For REVLIMID - Quick Facts
2/18/2015 9:41:00 AM - RTT News


Analysts' Actions: Celgene, Legg Mason, Rackspace, Williams-Sonoma
2/18/2015 7:54:00 AM - TheStreet


Lowe's Is A Terrific Company - Cramer's Lightning Round (2/17/15)
2/18/2015 5:37:00 AM - Seeking Alpha


Gilead Sciences Or Celgene, Which One Is A Better Investment?
2/17/2015 12:28:00 PM - Seeking Alpha


Jim Cramer's Stop Trading: Apache Has Room to Rise, J&J Takes It on the Chin
2/13/2015 1:19:00 PM - TheStreet


Disney Is A Long-Term Buy - Cramer's Lightning Round (2/12/15)
2/13/2015 5:32:00 AM - Seeking Alpha


Brookdale Senior Living in final phase of strategic transactions
2/12/2015 1:38:00 PM - Market Realist


Regional Banks Are The Way To Go - Cramer's Lightning Round (2/11/15)
2/12/2015 6:05:00 AM - Seeking Alpha